StonvexLoading…
StonvexStonvexStonvexCore line items from PDEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $57.14M | $37.19M | $18.53M | $66.59M |
Operating Income | $9.46M | $6.37M | $3.11M | $10.69M |
Net Income | $10.80M | $6.87M | $4.68M | $8.98M |
EPS (Diluted) | $3.27 | $2.07 | $1.40 | $2.67 |
Total Assets | $74.98M | $62.26M | $64.30M | $61.19M |
Total Liabilities | $29.78M | $20.63M | $22.79M | $24.56M |
Cash & Equivalents | $6.63M | $5.27M | $33.00K | $33.00K |
Free Cash Flow OCF − CapEx | $7.24M | $5.71M | $2.21M | Not available |
Shares Outstanding | 3.20M | 3.21M | 3.26M | 3.26M |